Oral Corticosteroid Therapy as an Adjuvant Treatment for Acute Bleeding in Hemophilia Patients With High Titer Inhibitors.


Journal

Journal of pediatric hematology/oncology
ISSN: 1536-3678
Titre abrégé: J Pediatr Hematol Oncol
Pays: United States
ID NLM: 9505928

Informations de publication

Date de publication:
01 03 2021
Historique:
received: 12 06 2019
accepted: 16 09 2019
pubmed: 7 11 2019
medline: 7 4 2021
entrez: 6 11 2019
Statut: ppublish

Résumé

Treatment options exist for patients with severe hemophilia and high titer factor VIII inhibitors but is often inadequate. Few studies have been conducted to evaluate the utility of short-term corticosteroid therapy for improvement in bleeding complications and temporary or sustained resolution of inhibitors in these patients. We describe 2 patients with acute muscular hematomas successfully treated with 4 to 5 days of oral adjuvant corticosteroid therapy resulting in improvement in their acute bleeds and temporary reduction of inhibitors. Thus, the addition of corticosteroids to traditional therapy of hemophilia with inhibitors may be beneficial in some patients. In those with impending compartment syndrome steroids may improve edema and bleeding symptoms preventing the need for surgical interventions.

Identifiants

pubmed: 31688638
pii: 00043426-202103000-00032
doi: 10.1097/MPH.0000000000001639
doi:

Substances chimiques

Adrenal Cortex Hormones 0
Factor VIII 9001-27-8

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e237-e239

Informations de copyright

Copyright © 2019 Wolters Kluwer Health, Inc. All rights reserved.

Déclaration de conflit d'intérêts

The authors declare no conflict of interest.

Références

Hoyer LW. The incidence of factor VIII inhibitors in patients with severe hemophilia A. Adv Exp Med Biol. 1995;386:35–45.
Kershaw G. Detection and measurement of factor inhibitors. Methods Mol Biol. 2017;1646:295–304.
Ljung RCR. How I manage patients with inherited haemophilia A and B and factor inhibitors. Br J Haematol. 2017;180:501–510.
Santagostino E, Morfini M, Auerswald GK, et al. Paediatric haemophilia with inhibitors: existing management options, treatment gaps and unmet needs. Haemophilia. 2009;15:983–989.
DiMichele DM. Inhibitor treatment in haemophilias A and B: inhibitor diagnosis. Haemophilia . 2006;12(suppl 6):37–41; discussion 41–42.
DiMichele DM, Hoots WK, Pipe SW, et al. International workshop on immune tolerance induction: consensus recommendations. Haemophilia. 2007;13(suppl 1):1–22.
Medeiros D, Laufenberg JA, Miller KL, et al. Short-term oral corticosteroid therapy for acute haemarthrosis in haemophilia patients with high-titre inhibitors. Haemophilia. 2007;13:85–89.
Key NS, Aledort LM, Beardsley D, et al. Home treatment of mild to moderate bleeding episodes using recombinant factor VIIa (Novoseven) in haemophiliacs with inhibitors. Thromb Haemost. 1998;80:912–918.
Santagostino E, Mancuso ME, Rocino A, et al. A prospective randomized trial of high and standard dosages of recombinant factor VIIa for treatment of hemarthroses in hemophiliacs with inhibitors. J Thromb Haemost. 2006;4:367–371.
Kempton CL, White GC. How we treat a hemophilia A patient with a factor VIII inhibitor. Blood. 2009;113:11–17.
Abildgaard CF, Simone JV, Schulnab I. Steroid treatmnet of hemophilic hematuria. J Pediatr. 1965;66:117–119.
Katsumi O. On hemostatic studies in hemophilia. Nagoya J Med Sci. 1966;28:196–203.
Kisker CT, Burke C. Double-blind studies on the use of steroids in the treatment of acute hemarthrosis in patients with hemophilia. N Engl J Med. 1970;282:639–642.
Rizza CR, Kernoff PB, Matthews JM, et al. A comparison of coagulation factor replacement with and without prednisolone in the treatment of haematuria in haemophilia and Christmas disease. Thromb Haemost. 1977;37:86–90.
Trieger N, McGovern JJ. Evaluation of corticosteroids in hemophilia. A controlled study during oral surgery. N Engl J Med. 1962;266:432–437.
Bennett AE, Ingram GI. A controlled trial of long-term steroid treatment in haemophilia. Lancet. 1967;1:967–970.
Bennett AE, Ingram GI. Steroid therapy for haemophilia. Lancet. 1970;1:476.
Binder RA, Durocher J, Mielke H. Treatment of pain in hemophilia. Effect of drugs on bleeding time. Am J Dis Child. 1974;127:371–373.
Canale VC, Hilgartner MW, Smith CH, et al. Effect of corticosteroids on factor 8 level. J Pediatr. 1967;71:878–880.
Gourdeau R, Denton RL. Steroids and hemophilia. Bibl Haematol. 1970;34:65–68.

Auteurs

Chantel Cacciotti (C)

Department of Pediatrics, McMaster Children's Hospital, Hamilton, ON.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH